Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2007
05/03/2007US20070099950 Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain
05/03/2007US20070099949 Method for Improving the Ability of Patients Suffering from Lung Diseases to Participate In and Benefit from Pulmonary Rehabilitation Programs
05/03/2007US20070099948 7-[4'S,5'R-4',6'-di-O-acetyl-2',3'-dideoxy-D-erythro-hex-2'-enopyranosyl]-oxymethyl camptothecin 20-(4-bromo)-n-butyrate; breast cancers, ovarian cancer, colon cancer, malignant melanoma, small cell lung cancer, thyroid cancers, lymphomas, leukemias, AIDS
05/03/2007US20070099947 Methods and compositions for the treatment of brain reward system disorders by combination therapy
05/03/2007US20070099946 Synthesis of R-N-methylnaltrexone
05/03/2007US20070099945 Novel tricyclic spiroderivatives as modulators of chemokine receptor acitivity
05/03/2007US20070099944 ROCK-1 kinase and/or Aurora kinase inhibitors; indazolo-tetrahydropyrimidine-carboxamide derivatives; 4-(4-fluorophenyl)-N-1H-indazol-5-yl-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxamide; antiinflammatory, antidiabetic, antiproliferative agents
05/03/2007US20070099943 Quinazoline derivatives
05/03/2007US20070099942 AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
05/03/2007US20070099941 N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
05/03/2007US20070099940 Pth agonists
05/03/2007US20070099938 Antistress drug and medical use thereof
05/03/2007US20070099937 Substituted Pyrrolones As Allosteric Modulators of Glucokinase
05/03/2007US20070099936 Dihydroisoindolones As Allosteric Modulators Of Glucokinase
05/03/2007US20070099935 Azole-based kinase inhibitors
05/03/2007US20070099934 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b
05/03/2007US20070099933 Indole derivatives as serotonin reuptake inhibitors
05/03/2007US20070099932 External preparation for athlete's foot treatment
05/03/2007US20070099931 Pharmaceutical dosage forms and compositions
05/03/2007US20070099930 Substituted Dihydroisoindolones As Allosteric Modulators of Glucokinase
05/03/2007US20070099929 Substituted thiophenes
05/03/2007US20070099928 Amine salts of (-)-2-{2-(4-hydroxyphenyl) ethyl]thio} -3-4-(2-{4-(methylsulfonyl) oxy phenyl propanoic acid and their use in medicine
05/03/2007US20070099927 Aminoalkyl-pyrazinones and-pyridones as thrombin inhibitors
05/03/2007US20070099926 Combination therapy for treating chronic inflammatory diseases
05/03/2007US20070099925 Novel imidazo based heterocycles
05/03/2007US20070099924 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
05/03/2007US20070099923 Therapeutic agents
05/03/2007US20070099922 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide
05/03/2007US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/03/2007US20070099920 Benzimidazoles useful as inhibitors of protein kinases
05/03/2007US20070099919 treating human immunodeficiency virus (HIV) infection in humans comprising administering 2-(4-Nitrophenylthio)-N-(2-methoxyphenyl)benzamide
05/03/2007US20070099918 Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH) / prostatic hypertrophy
05/03/2007US20070099917 Novel inhibitors and methods for their preparation
05/03/2007US20070099916 nuclear hormone receptor inhibitors; to treat increased lipid levels, increased cholesterol levels, low HDL-cholesterol, high LDL-cholesterol, atherosclerotic diseases, diabetes, macular degeneration, Alzheimer's disease; 2-(1-benzyl-3-chloro-2-methyl-1H-indol-5-yl)-1,1,1,3,3,3-hexafluoro-propan-2-ol
05/03/2007US20070099915 Inhibitors of the hiv integrase enzyme
05/03/2007US20070099914 Piperidine Derivatives
05/03/2007US20070099913 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods
05/03/2007US20070099912 Pyrrolo[2,3-F] and [3,2-F]Isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands
05/03/2007US20070099911 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands
05/03/2007US20070099910 Such as 1-[4-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)phenyl]-3-(2-fluoro-5-trifluoromethyl phenyl)urea; tyrosine kinase inhibitors, Raf kinase inhibitors; for treatment of tumors; pharmacokinetics; radiotherapy
05/03/2007US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
05/03/2007US20070099908 Arylsulfonyl chromans as 5-HT6 inhibitors
05/03/2007US20070099907 Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions
05/03/2007US20070099906 Combinations for the treatment of noeplastic disorders
05/03/2007US20070099905 Combinations of drugs for the treatment of neoplasms
05/03/2007US20070099904 Pharmaceutical composition for the treatment of cns and other disorders
05/03/2007US20070099903 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
05/03/2007US20070099902 Unitary pharmaceutical dosage form
05/03/2007US20070099901 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
05/03/2007US20070099900 Methods of modulating neurotrophin-mediated activity
05/03/2007US20070099899 Heterocyclic dihydropyrimidine compounds
05/03/2007US20070099898 2,4-benzodiazepine derivatives, used for treating cardiovascular diseases, cognitive and neurodegenerative diseases
05/03/2007US20070099897 Therapeutic compounds
05/03/2007US20070099896 5,7-Dimethyl-2-thiophen-3-yl-imidazo[1,2-a]pyridin-3-yl)-(1,1,3,3-tetramethylbutyl)-amine;vanilloid/cannabinoid receptor antagonists; analgesics, neuropathic pain; headaches; antiepileptic agents; emetic agents; eating disorders; hypotensive agents; antidepressants; glaucoma; incontinence; prion disease
05/03/2007US20070099895 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
05/03/2007US20070099894 e.g. 3-[(2,4-Difluorophenyl)amino]-2-{[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-7-phenylthieno[2,3-b]pyridin-6(7H)-one; autoimmune, neurodegenerative disorders, antiinflammatory agent; p38 MAP kinase inhibitor
05/03/2007US20070099893 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders
05/03/2007US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
05/03/2007US20070099891 Medicinal compositions and combinations
05/03/2007US20070099890 Novel cephalosporin derivatives, its pharmaceutically acceptable salts and manufacturing process thereof
05/03/2007US20070099889 Use of pseudan and pseudan inclusion bodies
05/03/2007US20070099888 Inflammation Inhibitor Comprising Zinc Salt of Acylamino Acid
05/03/2007US20070099887 Photodynamic therapy for the treatment of prostatic conditions
05/03/2007US20070099886 N-[(Hydroxyaryl)alkylidene]amino acids such as N-[(2,4-Dihydroxyphenyl)ethylidene]glycine or metal complexes, useful for the modulation of metal-activated enzymes and metalloenzymes, and as topical skin agents; prevention of acne and alopecia
05/03/2007US20070099885 Antibacterial macrocycles with substituted biphenyl
05/03/2007US20070099884 Combination therapy for the treatment of diabetes
05/03/2007US20070099883 Anhydrous mometasone furoate formulation
05/03/2007US20070099882 Methods and compositions for prolonged alleviation of articular joint pain
05/03/2007US20070099881 Method of treating wounds by enhancing expression of procollagen
05/03/2007US20070099880 Estrogen receptor modulators
05/03/2007US20070099879 retinopathy of prematurity, diabetic retinopathy and macular degeneration; inhibiting retinal endothelial cell capillary morphogenesis, or inhibiting retinal angiogenesis; administering vitamin D; calcitriol; ergocalciferol; cholecalciferol
05/03/2007US20070099878 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases
05/03/2007US20070099877 N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
05/03/2007US20070099876 Target directed chemotherapy of tumours of the sexual organs
05/03/2007US20070099875 Aspartyl protease inhibitors
05/03/2007US20070099874 Methods and compositions of novel triazine compounds
05/03/2007US20070099873 Quinolines useful as modulators of ion channels
05/03/2007US20070099872 Functionally selective alpha2C adrenoreceptor agonists
05/03/2007US20070099871 Bioreductively-activated prodrugs
05/03/2007US20070099870 Lipid analogs for combating tumors
05/03/2007US20070099869 Association product of α-glycosyl α,α-trehalose with ionic metal compound
05/03/2007US20070099868 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
05/03/2007US20070099867 Pharmaceutical agent containing hyaluronan as an active ingredient
05/03/2007US20070099866 Stable pharmaceutical compositions of 5,10-methylene tetrahydrofolate
05/03/2007US20070099865 administering adenosine receptor agonists such as N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide; vision defects
05/03/2007US20070099864 Use of o-atp for the treatment of diseases involving angiogenesis
05/03/2007US20070099863 Compounds for the treatment of demyelinating and autoimmune diseases
05/03/2007US20070099859 Phosphorus protecting groups
05/03/2007US20070099857 Methods and means for inhibiting fever
05/03/2007US20070099856 Combined treatment with docetaxel and an epidermal growth factor receptor kinase inhibitor using an intermittent dosing regimen
05/03/2007US20070099855 Glycyrrhizin or derivatives thereof for for treating or preventing severe acute respiratory syndrome (sars)
05/03/2007US20070099854 Use of pentadienoic acid derivatives for the treatment of hyperuricemia
05/03/2007US20070099853 Agent for improving physiological motor functions
05/03/2007US20070099852 Cucurbitacin compounds
05/03/2007US20070099851 Stable analogues of ribose-1-phosphate and methods for treating diabetes and other metabolic disorders
05/03/2007US20070099850 Combination of acetylsalicylic acid and alpha-glucosidase inhibitors
05/03/2007US20070099849 Co-Therapy for the Treatment of Migraine Comprising Anticonvulsant Derivatives and Anti-Migraine Agents
05/03/2007US20070099848 Rapamycin carbohydrate derivatives
05/03/2007US20070099847 Tyrosine kinase receptor antagonists and methods of treatment for pancreatic and breast cancer
05/03/2007US20070099846 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic
1 ... 3770 3771 3772 3773 3774 3775 3776 3777 3778 3779 3780 3781 3782 3783 3784 3785 3786 3787 3788 3789 3790 ... 7860